We thank Drs. Saraiva and Lobo for their thoughtful analysis of our work. We point out that in our Anesthesiology article, Akeju et al.,1  we took care to indicate that the propofol data came from a previous study, Purdon et al.,2  in which we cited the classic paper by Schnider et al.3  (see page 2, paragraph 2, of Purdon et al.2 ). In Purdon et al.,2  we used the Schnider model to administer propofol at target effect-site concentrations from 0 through 5 μg/ml to subjects executing an auditory task at 4-s intervals. The probability of response to these sounds was used to identify in each subject time points for loss and recovery of consciousness, which were used to identify electroencephalogram signatures of propofol-induced unconsciousness and sedation.2,4,5 

We analyzed the pharmacokinetic/pharmacodynamic (PK/PD) models used in target-controlled infusions and the electroencephalogram studies we have conducted over the past several years. As the authors suggested, we reexamined the effect-site concentrations associated with loss of consciousness for the subjects (18 to 36 yr of age) studied in Purdon et al.2  The effect-site concentrations from our subjects (fig. 1) reflect what we see everyday in the operating room: the doses required to induce unconsciousness with propofol vary widely from person to person. In this case, the propofol effect-site concentrations associated with loss of consciousness ranged from 1 to 4 μg/ml. Our data are consistent with previous studies. For instance, Iwakiri et al.,6  cited by Drs. Saraiva and Lobo, showed that patients lost consciousness at propofol effect-site concentrations between 0.7 and 4.8 μg/ml. The strategy underlying target-controlled infusion is that if we cannot observe a patient’s response to propofol, we use a population-based PK/PD model to select a dose that is approximately correct. These data show that the PK/PD estimate is likely to be inaccurate in an individual patient. Expecting a population-based measure of anesthetic effect to produce exactly the same effect in every patient is analogous to expecting 80 μg of phenylephrine to raise every patient’s systolic blood pressure by 15 mmHg.

Fig. 1.

Histogram of predicted propofol effect-site concentrations associated with loss of consciousness, from subjects studied in Purdon et al.2  administered using the Schnider model.3 

Fig. 1.

Histogram of predicted propofol effect-site concentrations associated with loss of consciousness, from subjects studied in Purdon et al.2  administered using the Schnider model.3 

Close modal

What if instead the anesthesiologist could track in real time a marker of an individual patient’s propofol-induced brain state? Recent work suggests that this is highly tractable using the electroencephalogram. In Purdon et al.,2  we show the electroencephalogram signatures associated with unconsciousness: a combination of slow (< 1 Hz) oscillations and alpha (8 to 14 Hz) oscillations (fig. 2, reproduced with permission). Although it is possible to recognize these oscillations in unprocessed electroencephalogram recordings,7–9  they are clearly evident in the spectrogram, which is the frequency distribution of the electroencephalogram power displayed as a function of time (fig. 2). We observe this propofol-induced signature of unconsciousness every day in the operating room.10  These propofol-induced electroencephalogram oscillations are among the largest neurophysiological signals seen in neuroscience,1  have been reported by a number of other researchers,11–14  and relate fundamentally to the neurophysiological mechanisms by which propofol produces unconsciousness.2,15–20 

Fig. 2.

Electroencephalogram signature of propofol-induced unconsciousness. (A) Probability of response curves for less salient auditory click stimuli (blue, Pclicks) and more salient verbal stimuli (red, Pverbal), pooled across the cohort of subjects. Time points for loss of consciousness (LOC) and recovery of consciousness (ROC) were identified for each subject using the individual subject response curves. (B) Baseline-normalized spectrograms from a frontal channel aligned with respect to LOC and ROC. The spectrogram quantifies the power in the electroencephalogram as a function of time (x-axis) and frequency (y-axis). The white contour circumscribes the regions where power differs significantly from baseline (P < 0.05, sign test) and indicates significant increases in power spanning low frequency (0.1 to 1 Hz) through gamma (25 to 35 Hz) bands. The largest oscillations are in the slow (0.1 to 1 Hz) and alpha (8 to 14 Hz) bands. Adapted from Purdon PL, Pierce ET, Mukamel EA, Prerau MJ, Walsh JL, Wong KF, Salazar-Gomez AF, Harrell PG, Sampson AL, Cimenser A, Ching S, Kopell NJ, Tavares-Stoeckel C, Habeeb K, Merhar R, Brown EN: Electroencephalogram signatures of loss and recovery of consciousness from propofol. Proc Natl Acad Sci U S A 2013; 110:E1142–51. (Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.)

Fig. 2.

Electroencephalogram signature of propofol-induced unconsciousness. (A) Probability of response curves for less salient auditory click stimuli (blue, Pclicks) and more salient verbal stimuli (red, Pverbal), pooled across the cohort of subjects. Time points for loss of consciousness (LOC) and recovery of consciousness (ROC) were identified for each subject using the individual subject response curves. (B) Baseline-normalized spectrograms from a frontal channel aligned with respect to LOC and ROC. The spectrogram quantifies the power in the electroencephalogram as a function of time (x-axis) and frequency (y-axis). The white contour circumscribes the regions where power differs significantly from baseline (P < 0.05, sign test) and indicates significant increases in power spanning low frequency (0.1 to 1 Hz) through gamma (25 to 35 Hz) bands. The largest oscillations are in the slow (0.1 to 1 Hz) and alpha (8 to 14 Hz) bands. Adapted from Purdon PL, Pierce ET, Mukamel EA, Prerau MJ, Walsh JL, Wong KF, Salazar-Gomez AF, Harrell PG, Sampson AL, Cimenser A, Ching S, Kopell NJ, Tavares-Stoeckel C, Habeeb K, Merhar R, Brown EN: Electroencephalogram signatures of loss and recovery of consciousness from propofol. Proc Natl Acad Sci U S A 2013; 110:E1142–51. (Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.)

Close modal

The pharmacodynamics component of the Schnider model is informed by an electroencephalogram representation that quantifies power within different frequency bands.3  In the Schnider model, the most significant indicators of propofol’s drug effect correspond to the alpha oscillation (fig. 3).3  This observation is completely consistent with the fact that the alpha oscillation is one of the two electroencephalogram oscillations associated with propofol-induced unconsciousness.2,11,12,16 * However, it further suggests that we could administer propofol with much greater accuracy in individual patients by simply monitoring the electroencephalogram and titrating the anesthetic to the desired electroencephalogram signature. We have shown that like propofol, each anesthetic has a distinct electroencephalogram signature.1,10,2123 

Fig. 3.

Coefficients of the “canonical univariate parameter” (CUP) used in Schnider et al.3  to characterize propofol pharmacodynamics. The largest coefficients correspond to the alpha oscillation, one of the electroencephalogram signatures of propofol-induced unconsciousness, shown in figure 2.

Fig. 3.

Coefficients of the “canonical univariate parameter” (CUP) used in Schnider et al.3  to characterize propofol pharmacodynamics. The largest coefficients correspond to the alpha oscillation, one of the electroencephalogram signatures of propofol-induced unconsciousness, shown in figure 2.

Close modal

In anesthesiology, the electroencephalogram is often viewed synonymously with processed electroencephalogram indices designed to indicate “depth of anesthesia” using a single number between 0 and 100. These indices have been designed with a one-size-fits-all approach in which the same index value is meant to represent the same state of unconsciousness, regardless of the anesthetic being administered, and without regard to significant age-dependent differences in anesthesia-induced electroencephalogram features.2426  Anesthesiologists have learned over the years that their use does not reduce the incidence of awareness27  and that patients’ underlying brain states can vary substantially despite being maintained within the recommended index range.26,28,29  Alternatively, the unprocessed electroencephalogram and its spectrogram make it possible to view directly the patient’s brain states under general anesthesia.23  Over the past several years, we have been teaching anesthesiologists at our institution to read the unprocessed electroencephalogram and its spectrogram. The spectrogram makes the electroencephalogram easier to read and relate to underlying systems neuroscience mechanisms. Our course, “Clinical Electroencephalography for the Anesthesiologist,” can be accessed online, free of charge, at www.AnesthesiaEEG.com. A significant challenge in teaching the electroencephalogram has been the perceived complexity of the signal, but with appropriate application of modern signal processing methods,1,2,10,30  the structure of anesthesia-induced electroencephalogram oscillations becomes much easier to discern. It is not surprising that these electroencephalogram signatures may have been overlooked previously in the absence of appropriate methods to visualize them. Using the unprocessed electroencephalogram and its spectrogram, electroencephalogram signatures associated with brain states during general anesthesia and sedation are easy to discern and interpret.

In the United States, we are eagerly awaiting newly proposed programs to support research on personalized medicine,31  with the hope that at some point in the future, we can administer therapies tailored uniquely to each patient’s specific needs. An example would be choosing the correct dose of medication for every individual. In anesthesiology, we can move toward personalized anesthesia care by using a “missing piece” of information that has been hiding in plain sight all along: the electroencephalogram.

Drs. Purdon (DP2-OD006454), Brown (DP1-OD003646 and TR01-GM104948), and Akeju (T32GM007592) received funding from the National Institutes of Health, Bethesda, Maryland. Dr. Akeju received funding from the Foundation of Anesthesia Education and Research, Rochester, Minnesota; Massachusetts General Hospital Faculty Development Award, Boston, Massachusetts; and Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts.

Drs. Purdon, Akeju, and Brown have submitted patent applications describing the use of the electroencephalogram for monitoring sedation and general anesthesia. Some of these patents have been licensed to Masimo Corporation (Irvine, California) by Massachusetts General Hospital (Boston, Massachusetts). Drs. Purdon, Akeju, and Brown are due to receive institutionally distributed royalties under this licensing agreement. Drs. Purdon and Brown have consulting agreements with Masimo Corporation. Mr. Zhou declares no competing interests.

*

We conjecture that the slow oscillation may have been absent in Schnider et al.3  due to the choice of the frequency bands for the “canonical univariate parameter” or perhaps due to the choice of electroencephalogram filtering parameters.

1.
Akeju
O
,
Pavone
KJ
,
Westover
MB
,
Vazquez
R
,
Prerau
MJ
,
Harrell
PG
,
Hartnack
KE
,
Rhee
J
,
Sampson
AL
,
Habeeb
K
,
Gao
L
,
Lei
G
,
Pierce
ET
,
Walsh
JL
,
Brown
EN
,
Purdon
PL
:
A comparison of propofol- and dexmedetomidine-induced electroencephalogram dynamics using spectral and coherence analysis.
Anesthesiology
2014
;
121
:
978
89
2.
Purdon
PL
,
Pierce
ET
,
Mukamel
EA
,
Prerau
MJ
,
Walsh
JL
,
Wong
KF
,
Salazar-Gomez
AF
,
Harrell
PG
,
Sampson
AL
,
Cimenser
A
,
Ching
S
,
Kopell
NJ
,
Tavares-Stoeckel
C
,
Habeeb
K
,
Merhar
R
,
Brown
EN
:
Electroencephalogram signatures of loss and recovery of consciousness from propofol.
Proc Natl Acad Sci U S A
2013
;
110
:
E1142
51
3.
Schnider
TW
,
Minto
CF
,
Shafer
SL
,
Gambus
PL
,
Andresen
C
,
Goodale
DB
,
Youngs
EJ
:
The influence of age on propofol pharmacodynamics.
Anesthesiology
1999
;
90
:
1502
16
4.
Wong
KF
,
Smith
AC
,
Pierce
ET
,
Harrell
PG
,
Walsh
JL
,
Salazar-Gomez
AF
,
Tavares
CL
,
Purdon
PL
,
Brown
EN
:
Statistical modeling of behavioral dynamics during propofol-induced loss of consciousness.
J Neurosci Methods
2014
;
227
:
65
74
5.
Smith
AC
,
Wirth
S
,
Suzuki
WA
,
Brown
EN
:
Bayesian analysis of interleaved learning and response bias in behavioral experiments.
J Neurophysiol
2007
;
97
:
2516
24
6.
Iwakiri
H
,
Nishihara
N
,
Nagata
O
,
Matsukawa
T
,
Ozaki
M
,
Sessler
DI
:
Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening.
Anesth Analg
2005
;
100
:
107
10
7.
Bennett
C
,
Voss
LJ
,
Barnard
JP
,
Sleigh
JW
:
Practical use of the raw electroencephalogram waveform during general anesthesia: The art and science.
Anesth Analg
2009
;
109
:
539
50
8.
Martin
JT
,
Faulconer
A
Jr
,
Bickford
RG
:
Electroencephalography in anesthesiology.
Anesthesiology
1959
;
20
:
359
76
9.
Gibbs
FA
,
Gibbs
EL
,
Lennox
WG
:
Effect on the electroencephalogram of certain drugs which influence nervous activity.
Arch Intern Med
1937
;
60
:
154
169
10.
Akeju
O
,
Westover
MB
,
Pavone
KJ
,
Sampson
AL
,
Hartnack
KE
,
Brown
EN
,
Purdon
PL
:
Effects of sevoflurane and propofol on frontal electroencephalogram power and coherence.
Anesthesiology
2014
;
121
:
990
8
11.
Feshchenko
VA
,
Veselis
RA
,
Reinsel
RA
:
Propofol-induced alpha rhythm.
Neuropsychobiology
2004
;
50
:
257
66
12.
Supp
GG
,
Siegel
M
,
Hipp
JF
,
Engel
AK
:
Cortical hypersynchrony predicts breakdown of sensory processing during loss of consciousness.
Curr Biol
2011
;
21
:
1988
93
13.
Murphy
M
,
Bruno
MA
,
Riedner
BA
,
Boveroux
P
,
Noirhomme
Q
,
Landsness
EC
,
Brichant
JF
,
Phillips
C
,
Massimini
M
,
Laureys
S
,
Tononi
G
,
Boly
M
:
Propofol anesthesia and sleep: A high-density EEG study.
Sleep
2011
;
34
:
283
91A
14.
Ní Mhuircheartaigh
R
,
Warnaby
C
,
Rogers
R
,
Jbabdi
S
,
Tracey
I
:
Slow-wave activity saturation and thalamocortical isolation during propofol anesthesia in humans.
Sci Transl Med
2013
;
5
:
208ra148
15.
Lewis
LD
,
Weiner
VS
,
Mukamel
EA
,
Donoghue
JA
,
Eskandar
EN
,
Madsen
JR
,
Anderson
WS
,
Hochberg
LR
,
Cash
SS
,
Brown
EN
,
Purdon
PL
:
Rapid fragmentation of neuronal networks at the onset of propofol-induced unconsciousness.
Proc Natl Acad Sci U S A
2012
;
109
:
E3377
86
16.
Cimenser
A
,
Purdon
PL
,
Pierce
ET
,
Walsh
JL
,
Salazar-Gomez
AF
,
Harrell
PG
,
Tavares-Stoeckel
C
,
Habeeb
K
,
Brown
EN
:
Tracking brain states under general anesthesia by using global coherence analysis.
Proc Natl Acad Sci U S A
2011
;
108
:
8832
7
17.
Ching
S
,
Cimenser
A
,
Purdon
PL
,
Brown
EN
,
Kopell
NJ
:
Thalamocortical model for a propofol-induced alpha-rhythm associated with loss of consciousness.
Proc Natl Acad Sci U S A
2010
;
107
:
22665
70
18.
Brown
EN
,
Lydic
R
,
Schiff
ND
:
General anesthesia, sleep, and coma.
N Engl J Med
2010
;
363
:
2638
50
19.
Brown
EN
,
Purdon
PL
,
Van Dort
CJ
:
General anesthesia and altered states of arousal: A systems neuroscience analysis.
Annu Rev Neurosci
2011
;
34
:
601
28
20.
Mukamel
EA
,
Pirondini
E
,
Babadi
B
,
Wong
KF
,
Pierce
ET
,
Harrell
PG
,
Walsh
JL
,
Salazar-Gomez
AF
,
Cash
SS
,
Eskandar
EN
,
Weiner
VS
,
Brown
EN
,
Purdon
PL
:
A transition in brain state during propofol-induced unconsciousness.
J Neurosci
2014
;
34
:
839
45
21.
Brown
EN
,
Solt
K
,
Purdon
PL
,
Akeju
O
:
Monitoring brain state during general anesthesia and sedation
in
Miller’s Anesthesia
, 8th edition. Edited by
Miller
RD
,
Cohen
NH
,
Eriksson
LI
,
Fleisher
LA
,
Wiener-Kronish
JP
,
Young
WL
.
Elsevier
,
2014
, pp
1524
40
22.
Purdon
PL
,
Brown
EN
:
Clinical Electroencephalography for Anesthesiologists the Anesthesiologist
.
Boston
,
Partners Healthcare Office of Continuing Professional Development
,
2014
Available at: AnesthesiaEEG.com. Accessed July 17, 2015
23.
Purdon
PL
,
Sampson
AL
,
Pavone
KJ
,
Brown
EN
:
Clinical electroencephalography for anesthesiologists, part I: Background and basic signatures.
Anesthesiology
2015
in press
24.
Purdon
PL
,
Pavone
KJ
,
Akeju
O
,
Smith
AC
,
Sampson
AL
,
Lee
J
,
Zhou
DW
,
Solt
K
,
Brown
EN
:
The aging brain: An age-dependent analysis of the electroencephalogram during propofol and sevoflurane general anesthesia.
Br J Anaesth
2015
in press
25.
Akeju
O
,
Pavone
KJ
,
Thum
JA
,
Firth
PG
,
Westover
MB
,
Puglia
M
,
Shank
ES
,
Brown
EN
,
Purdon
PL
:
An age-dependent analysis of sevoflurane-induced electroencephalogram dynamics in children.
Br J Anaesth
2015
26.
Besch
G
,
Liu
N
,
Samain
E
,
Pericard
C
,
Boichut
N
,
Mercier
M
,
Chazot
T
,
Pili-Floury
S
:
Occurrence of and risk factors for electroencephalogram burst suppression during propofol-remifentanil anaesthesia.
Br J Anaesth
2011
;
107
:
749
56
27.
Avidan
MS
,
Jacobsohn
E
,
Glick
D
,
Burnside
BA
,
Zhang
L
,
Villafranca
A
,
Karl
L
,
Kamal
S
,
Torres
B
,
O’Connor
M
,
Evers
AS
,
Gradwohl
S
,
Lin
N
,
Palanca
BJ
,
Mashour
GA
;
BAG-RECALL Research Group
:
Prevention of intraoperative awareness in a high-risk surgical population.
N Engl J Med
2011
;
365
:
591
600
28.
Whitlock
EL
,
Villafranca
AJ
,
Lin
N
,
Palanca
BJ
,
Jacobsohn
E
,
Finkel
KJ
,
Zhang
L
,
Burnside
BA
,
Kaiser
HA
,
Evers
AS
,
Avidan
MS
:
Relationship between bispectral index values and volatile anesthetic concentrations during the maintenance phase of anesthesia in the B-Unaware trial.
Anesthesiology
2011
;
115
:
1209
18
29.
Sleigh
JW
:
Depth of anesthesia: Perhaps the patient isn't a submarine.
Anesthesiology
2011
;
115
:
1149
50
30.
Babadi
B
,
Brown
EN
:
A review of multitaper spectral analysis.
IEEE Trans Biomed Eng
2014
;
61
:
1555
64
31.
Dennis
B
:
Obama touts ‘lifesaving’ potential of personalized medicine
Washington Post
,
2015